Latest in News & Research

Is Efficacy Sustained for Approved Dose of Ixekizumab Over Five Years?

≥75 percent improvement from baseline in Psoriasis Area and Severity Index was achieved by 78.8 percent at week 264

By Dermsquared Editorial Team | | July 28, 2021

Acne Negatively Impacts Emotional Health of Adult Women

Adult women with acne describe disruption to their personal and professional lives

By Physician’s Briefing Staff | | July 28, 2021

Elimination Diets Aid Eczema Severity Only Modestly

Authors warn of some potential downsides to inform decision-making

By Physician’s Briefing Staff | | July 26, 2021

Disparities Seen for Racial, Ethnic Minorities in Outpatient Practices

Visit rates lower for Black individuals versus Whites for 23 of 29 specialties, with marked disparities for dermatology, otolaryngology, general surgery

By Physician's Briefing Staff | | July 23, 2021

Guidelines Updated for Treatment of Sexually Transmitted Infections

Updated recommendations include alternative regimens for bacterial vaginosis, management of 

By Physician's Briefing Staff | | July 22, 2021

Is Risk for Infection Increased With Biologic Use in Psoriasis?

Risk for serious infections increased for new users of adalimumab, infliximab versus etanercept; reduced with ustekinumab

By Dermsquared Editorial Team | | July 21, 2021

Risk for Psoriasis Increased for Cancer Survivors

Increased risks seen for survivors of leukemia, lymphoma, multiple myeloma, skin cancer, and lung cancer in subgroup analyses

By Physician’s Briefing Staff | | July 21, 2021

Gender-Affirming Hair Removal Improves Mental Health

Odds of psychological distress, smoking, suicidal intent reduced among transgender and gender-diverse adults assigned male at birth

By Physician’s Briefing Staff | | July 21, 2021

AI System Could Help Clinicians Assess Psoriasis Severity

Novel simplified scoring system and associated AI model could help dermatologists quickly evaluate psoriasis severity

By Physician’s Briefing Staff | | July 21, 2021

Five Neutrogena and Aveeno Spray Sunscreens Recalled Due to Benzene

Johnson & Johnson said it was still investigating how traces of benzene were discovered in the sunscreens

By Physician’s Briefing Staff | | July 15, 2021

How Effective Is Cemiplimab for Advanced, Metastatic BCC?

Case report shows benefit for cemiplimab in patient with locally advanced ulcerated cSCC, two infiltrative BCCs

By Dermsquared Editorial Team | | July 14, 2021

Minocycline-Induced Hyperpigmentation Described in Elderly Male

Patient presented for examination of facial and ocular discoloration; eight-year history of minocycline use for acne vulgaris identified

By Dermsquared Editorial Team | | July 14, 2021

Questionnaire Responses About Dermatology History Inconsistent

History of psoriasis consistently reported, whereas history of atopic dermatitis is not

By Physician’s Briefing Staff | | July 13, 2021

Pfizer-BioNTech COVID-19 Vaccine Safe, Effective in Cancer Patients

Pronounced lag in antibody production after the first dose found versus noncancer controls

By Physician’s Briefing Staff | | July 13, 2021

Androgenetic Alopecia May Reduce Health-Related Quality of Life

Authors say patients with androgenetic alopecia may need psychological, psychosocial support

By Physician’s Briefing Staff | | July 12, 2021

Teens, Parents View Provider Sexual Health Discussions as Important

However, less than one-third of teens reported discussions about sexual and reproductive health topics other than puberty at most recent visit

By Physician’s Briefing Staff | | July 12, 2021

U.S. Cancer Mortality Rates Down From 2014 to 2018

Decrease seen for 11 of the 19 most common cancers among men and for 14 of the 20 most common cancers among women

By Physician’s Briefing Staff | | July 08, 2021

Can Primary Tumor Site Predict Merkel Cell Carcinoma Outcomes?

Tumors involving the scalp/neck carry the highest cumulative Merkel cell carcinoma-specific mortality incidence

By Dermsquared Editorial Team | | July 07, 2021

What Skin Reactions Are Seen After mRNA COVID-19 Vaccines?

Most common reactions include delayed large local reactions, local injection site reactions, urticaria, and morbilliform eruptions

By Dermsquared Editorial Team | | July 07, 2021

Immunocompromised? Why the COVID-19 Vaccine Might Still Protect You

WEDNESDAY, July 7, 2021 (HealthDay News) -- COVID-19 vaccinations may not offer as much protection to people with compromised immune systems, but just how...

By Denise Mann (HealthDay News) | | July 07, 2021

Prevalence of Psoriasis 3 Percent in U.S. Population Age Twenty-Plus

Prevalence similar for women and men, highest among Whites, not significantly different from 2003

By Dermsquared Editorial Team | | July 06, 2021

Shining a Light on Sunscreens

Sunscreen isn't just for pool gatherings and beach outings: Using sunscreen every day could reduce your risk of skin cancer, experts say.

Daily use...

By Robert Preidt (HealthDay News) | | July 03, 2021

Risk of Migraine May Be Higher With Rosacea

Men with rosacea have twice the risk for self-reported migraine versus those without rosacea

By Physician’s Briefing Staff | | July 01, 2021

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026